These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 22585693)

  • 1. Cytogenetics, not just previous therapy, determines the course of therapy-related myeloid neoplasms.
    Larson RA
    J Clin Oncol; 2012 Jul; 30(19):2300-2. PubMed ID: 22585693
    [No Abstract]   [Full Text] [Related]  

  • 2. Susceptibility to therapy-related myelodysplastic syndromes and acute myeloid leukemia.
    Sill H
    Clin Adv Hematol Oncol; 2008 Mar; 6(3):164-5. PubMed ID: 18391913
    [No Abstract]   [Full Text] [Related]  

  • 3. Secondary leukemia and myelodysplastic syndrome after treatment for Hodgkin's disease.
    Hoppe RT
    Leukemia; 1992 Nov; 6 Suppl 4():155-7. PubMed ID: 1434819
    [No Abstract]   [Full Text] [Related]  

  • 4. Risk of therapy-related myelodysplastic syndrome/acute myeloid leukemia after childhood cancer: a population-based study.
    Advani PG; Schonfeld SJ; Curtis RE; Dores GM; Linet MS; Sigel BS; Lam CJK; Tucker MA; Chanock SJ; Morton LM
    Leukemia; 2019 Dec; 33(12):2947-2978. PubMed ID: 31341236
    [No Abstract]   [Full Text] [Related]  

  • 5. Comprehensive analysis of factors impacting risks and outcomes of therapy-related myeloid neoplasms following breast cancer treatment.
    Sevcikova K; Zhuang Z; Garcia-Manero G; Alvarez RH; Kantarjian HM; Mego M; Albarracin C; Tang G; Strom SS; Medeiros LJ; Hortobagyi GN; Reuben JM; Khoury JD
    Leukemia; 2016 Jan; 30(1):242-7. PubMed ID: 25975189
    [No Abstract]   [Full Text] [Related]  

  • 6. Are myelodysplastic syndromes and acute myeloid leukaemia occurring during the course of lymphoma always therapy related?
    Bigenwald C; Harel S; Chevignon F; Roos-Weil D; Bernard OA; Amorim S; Brice P; Adès L; Nloga AM; Sébert M; Braun T; Eclache V; Thieblemont C; Fenaux P
    Br J Haematol; 2018 Jan; 180(2):304-308. PubMed ID: 27662562
    [No Abstract]   [Full Text] [Related]  

  • 7. The heterogeneity of leukemia occurring after treatment for sarcoma.
    Varterasian M; Zalupski M; Karanes C
    Am J Clin Oncol; 1997 Dec; 20(6):585-6. PubMed ID: 9391546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of histological transformation and therapy-related myelodysplasia/acute myeloid leukaemia in patients receiving radioimmunotherapy for follicular lymphoma.
    Epperla N; Pham AQ; Burnette BL; Wiseman GA; Habermann TM; Macon WR; Ansell SM; Inwards DJ; Micallef IN; Johnston PB; Markovic SN; Porrata LF; Colgan JP; Ristow KM; Nowakowski GS; Witzig TE
    Br J Haematol; 2017 Aug; 178(3):427-433. PubMed ID: 28466487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Why is there so much therapy-related AML and MDS and so little therapy-related CML?
    Gale RP; Hlatky L; Sachs RK; Radivoyevitch T
    Leuk Res; 2014 Oct; 38(10):1162-4. PubMed ID: 25175829
    [No Abstract]   [Full Text] [Related]  

  • 10. Therapy-related acute leukemia.
    Karp JE; Sarkodee-Adoo CB
    Clin Lab Med; 2000 Mar; 20(1):71-81, ix. PubMed ID: 10702897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myelodysplastic syndrome in a child with a history of medulloblastoma.
    Akyüz C; Emir S; Güler N; Tüker A; Büyükpamukçu M
    Turk J Pediatr; 1998; 40(1):131-4. PubMed ID: 9673540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of therapy-related myelodysplastic syndromes and acute myeloid leukaemia (t-MDS/AML) in Irish patients: a single centre experience.
    Maung SW; Burke C; Hayde J; Walshe J; McDermott R; Desmond R; McHugh J; Enright H
    Hematology; 2017 Jul; 22(6):341-346. PubMed ID: 28196450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preleukaemic clonal haemopoiesis and risk of therapy-related myeloid neoplasms: a case-control study.
    Takahashi K; Wang F; Kantarjian H; Doss D; Khanna K; Thompson E; Zhao L; Patel K; Neelapu S; Gumbs C; Bueso-Ramos C; DiNardo CD; Colla S; Ravandi F; Zhang J; Huang X; Wu X; Samaniego F; Garcia-Manero G; Futreal PA
    Lancet Oncol; 2017 Jan; 18(1):100-111. PubMed ID: 27923552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of myelodysplastic syndrome and acute myeloid leukemia post radiation treatment for breast cancer: a population-based study.
    Kaplan H; Malmgren J; De Roos AJ
    Breast Cancer Res Treat; 2013 Feb; 137(3):863-7. PubMed ID: 23274844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and susceptibility to therapy-related myeloid neoplasms.
    Leone G; Fianchi L; Pagano L; Voso MT
    Chem Biol Interact; 2010 Mar; 184(1-2):39-45. PubMed ID: 20026017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of patients who develop acute leukemia or myelodysplasia as a second malignancy after solid tumors treated surgically or with strategies that include chemotherapy and/or radiation.
    Abdelhameed A; Pond GR; Mitsakakis N; Brandwein J; Chun K; Gupta V; Kamel-Reid S; Lipton JH; Minden MD; Schimmer A; Schuh A; Yee K; Messner HA
    Cancer; 2008 Apr; 112(7):1513-21. PubMed ID: 18286528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for second acute myeloid leukemia/myelodysplastic syndrome among survivors of non-Hodgkin lymphoma.
    Lam CJ; Curtis RE; Dores GM; Engels EA; Caporaso NE; Polliack A; Warren JL; Young HA; Levine PH; Elmi AF; Fraumeni JF; Tucker MA; Morton LM
    Leukemia; 2016 May; 30(5):1187-90. PubMed ID: 26369985
    [No Abstract]   [Full Text] [Related]  

  • 18. Myelodysplasia and acute leukemia following high-dose chemotherapy and autologous bone marrow or peripheral blood stem cell transplantation.
    Sobecks RM; Le Beau MM; Anastasi J; Williams SF
    Bone Marrow Transplant; 1999 Jun; 23(11):1161-5. PubMed ID: 10382956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary malignancies after therapy of indolent non-Hodgkin's lymphoma.
    Friedberg JW
    Haematologica; 2008 Mar; 93(3):336-8. PubMed ID: 18310538
    [No Abstract]   [Full Text] [Related]  

  • 20. Survival in multiple myeloma patients who develop second malignancies: a population-based cohort study.
    Jonsdottir G; Lund SH; Björkholm M; Turesson I; Wahlin A; Mailankody S; Blimark C; Hultcrantz M; Porwit A; Landgren O; Kristinsson SY
    Haematologica; 2016 Apr; 101(4):e145-8. PubMed ID: 26681760
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.